2012
DOI: 10.1016/j.ccr.2012.07.015
|View full text |Cite
|
Sign up to set email alerts
|

Control of Tumor Bioenergetics and Survival Stress Signaling by Mitochondrial HSP90s

Abstract: SUMMARY Tumors successfully adapt to constantly changing intra- and extra-cellular environments, but the wirings of this process are still largely elusive. Here, we show that Heat Shock Protein 90 (HSP90)-directed protein folding in mitochondria, but not cytosol, maintains energy production in tumor cells. Interference with this process activates a signaling network that involves phosphorylation of nutrient-sensing AMP-activated kinase (AMPK), inhibition of rapamycin-sensitive mTOR complex 1 (mTORC1), inductio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
132
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 106 publications
(144 citation statements)
references
References 40 publications
12
132
0
Order By: Relevance
“…Aerobic glycolysis is suppressed as a byproduct of this altered metabolic landscape, likely because of, in part, allosteric inhibition of the glycolytic enzyme phosphofructokinase. These data are in general agreement with a recent study showing that TRAP1 silencing in a glioblastoma cell line resulted in a variety of metabolic changes suggestive of reduced glycolysis, including reduced lactic acid secretion (44). Suppression of glycolysis concomitant with enhanced fatty acid oxidation and increased steady-state levels of several TCA cycle intermediates, including oxaloacetate, strongly suggest that TRAP1-deficient cells use one or more anaplerotic mechanisms to sustain their mitochondrial metabolism.…”
Section: Discussionsupporting
confidence: 81%
“…Aerobic glycolysis is suppressed as a byproduct of this altered metabolic landscape, likely because of, in part, allosteric inhibition of the glycolytic enzyme phosphofructokinase. These data are in general agreement with a recent study showing that TRAP1 silencing in a glioblastoma cell line resulted in a variety of metabolic changes suggestive of reduced glycolysis, including reduced lactic acid secretion (44). Suppression of glycolysis concomitant with enhanced fatty acid oxidation and increased steady-state levels of several TCA cycle intermediates, including oxaloacetate, strongly suggest that TRAP1-deficient cells use one or more anaplerotic mechanisms to sustain their mitochondrial metabolism.…”
Section: Discussionsupporting
confidence: 81%
“…In these experiments, noncytotoxic concentrations of Gamitrinib (23) suppressed the migration ( Figure 1A and Supplemental Figure 1A; supplemental material available online with this article; doi:10.1172/JCI67841DS1), and invasion ( Figure 1B and Supplemental Figure 1B) of tumor cell types. When tested in a more physiologic 3D model of cellular motility, Gamitrinib blocked tumor cell invasion in organotypic spheroids embedded in a collagen matrix ( Figure 1C), with nearly complete suppression of invasive length and invasive areas ( Figure 1D).…”
Section: Mitochondrial Hsp90 Regulation Of Tumor Cell Motilitymentioning
confidence: 99%
“…In addition to opposing CypD-dependent permeability transition (21), mitochondrial Hsp90s maintain ATP production in tumor cells via retention of HK-II to the organelle outer membrane (23). To test whether this function in bioenergetics was important for tumor cell motility, we next treated tumor cells with the mitochondrial uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and looked for changes in cell motility.…”
Section: Mitochondrial Hsp90 Regulation Of Tumor Cell Motilitymentioning
confidence: 99%
See 1 more Smart Citation
“…It can therefore be reasonably deduced that Hsp90 takes part in trafficking of Tom40 to the mitochondrial membrane. Interestingly, a significant role of the mitochondrial Hsp90 in keeping energy production in cancer cells has been observed recently [25,26]. In can be, therefore, assumed that blocking Hsp90 activity results in mitochondrial disruption and metabolic changes, however, the exact mechanism depends on the drug used and the part of Hsp90 affected.…”
Section: Metabolomic Analysis Of Cell Pellets (A) and Media (B-d) 4 mentioning
confidence: 99%